23andme glp-1 Unlocking the Genetics of Medications Unlocking the Genetics of GLP-1

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

Learn which liver enzyme tests matter, what your results mean, and how to monitor safely as you lose weight.

Bifidobacterium infantis promotes microbiome diversity

Finding an enzyme product that is both high potency and broad spectrum is key to achieving digestive support

New study examines GLP-1 drugs and a reduction in breast cancer risk